Published online before print November 26, 2007, doi: 10.1161/CIRCULATIONAHA.107.719005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;116:2694-2701.)
© 2007 American Heart Association, Inc.
Epidemiology |
Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men
European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study
From the Department of Public Health and Primary Care (K.-T.K., R.L., A.W., N.D.), Institute of Public Health, University of Cambridge School of Clinical Medicine, Cambridge, UK; Academic Department of Biochemistry (M.D., E.F.), Royal Marsden Hospital, London, UK; and MRC Dunn Human Nutrition Unit (S.B.) and MRC Epidemiology Unit (N.W.), Cambridge, UK.
Correspondence to Kay-Tee Khaw, Clinical Gerontology Unit Box 251, Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK. E-mail kk101{at}medschl.cam.ac.uk
Received June 1, 2007; accepted September 11, 2007.
Background— The relation between endogenous testosterone concentrations and health in men is controversial.
Methods and Results— We examined the prospective relationship between endogenous testosterone concentrations and mortality due to all causes, cardiovascular disease, and cancer in a nested case-control study based on 11 606 men aged 40 to 79 years surveyed in 1993 to 1997 and followed up to 2003. Among those without prevalent cancer or cardiovascular disease, 825 men who subsequently died were compared with a control group of 1489 men still alive, matched for age and date of baseline visit. Endogenous testosterone concentrations at baseline were inversely related to mortality due to all causes (825 deaths), cardiovascular disease (369 deaths), and cancer (304 deaths). Odds ratios (95% confidence intervals) for mortality for increasing quartiles of endogenous testosterone compared with the lowest quartile were 0.75 (0.55 to 1.00), 0.62 (0.45 to 0.84), and 0.59 (0.42 to 0.85), respectively (P<0.001 for trend after adjustment for age, date of visit, body mass index, systolic blood pressure, blood cholesterol, cigarette smoking, diabetes mellitus, alcohol intake, physical activity, social class, education, dehydroepiandrosterone sulfate, androstanediol glucuronide, and sex hormone binding globulin). An increase of 6 nmol/L serum testosterone (
1 SD) was associated with a 0.81 (95% confidence interval 0.71 to 0.92, P<0.01) multivariable-adjusted odds ratio for mortality. Inverse relationships were also observed for deaths due to cardiovascular causes and cancer and after the exclusion of deaths that occurred in the first 2 years.
Conclusions— In men, endogenous testosterone concentrations are inversely related to mortality due to cardiovascular disease and all causes. Low testosterone may be a predictive marker for those at high risk of cardiovascular disease.
CLINICAL PERSPECTIVE
Find additional patient-related information at:
This article has been cited by other articles:
 |
|
 |
|
  N. Gavrilova and S. T. Lindau Salivary Sex Hormone Measurement in a National, Population-Based Study of Older Adults J Gerontol B Psychol Sci Soc Sci, November 1, 2009; 64B(suppl_1): i94 - i105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. B Yeap, S A P. Chubb, Z. Hyde, K. Jamrozik, G. J Hankey, L. Flicker, and P. E Norman Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study Eur. J. Endocrinol., October 1, 2009; 161(4): 591 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. I Hackett Review: Androgens, erectile dysfunction and cardiovascular risk in type 2 diabetes The British Journal of Diabetes & Vascular Disease, September 1, 2009; 9(5): 214 - 217. [Abstract] [PDF]
|
|
|
|
|
|
T. Vikan, H. Schirmer, I. Njolstad, and J. Svartberg Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso Study Eur. J. Endocrinol., September 1, 2009; 161(3): 435 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mathur, C. Malkin, B. Saeed, R Muthusamy, T H. Jones, and K. Channer Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men Eur. J. Endocrinol., September 1, 2009; 161(3): 443 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Traish, F. Saad, R. J. Feeley, and A. Guay The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease J Androl, September 1, 2009; 30(5): 477 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Q. Reuwer, M. T. Twickler, B. A. Hutten, F. W. Molema, N. J. Wareham, G. M. Dallinga-Thie, R. L. Bogorad, V. Goffin, M. Smink-Bol, J. J.P. Kastelein, et al. Prolactin Levels and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women Circ Cardiovasc Genet, August 1, 2009; 2(4): 389 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. B. Yeap, Z. Hyde, O. P. Almeida, P. E. Norman, S. A. P. Chubb, K. Jamrozik, L. Flicker, and G. J. Hankey Lower Testosterone Levels Predict Incident Stroke and Transient Ischemic Attack in Older Men J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2353 - 2359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tivesten, L. Vandenput, F. Labrie, M. K. Karlsson, O. Ljunggren, D. Mellstrom, and C. Ohlsson Low Serum Testosterone and Estradiol Predict Mortality in Elderly Men J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2482 - 2488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Svartberg, S. K Braekkan, G. A Laughlin, and J.-B. Hansen Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study Eur. J. Endocrinol., May 1, 2009; 160(5): 833 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sanz, P. R. Moreno, and V. Fuster The year in atherothrombosis. J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1326 - 1337. [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Tharp, I. Masseau, J. Ivey, V. K. Ganjam, and D. K. Bowles Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine Cardiovasc Res, April 1, 2009; 82(1): 152 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Carrero, A. R. Qureshi, P. Parini, S. Arver, B. Lindholm, P. Barany, O. Heimburger, and P. Stenvinkel Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients J. Am. Soc. Nephrol., March 1, 2009; 20(3): 613 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T H. Jones Late onset hypogonadism BMJ, February 13, 2009; 338(feb13_1): b352 - b352. [Full Text]
|
|
|
|
 |
|
 G. Jackson CHAPTER 15c Erectile Dysfunction ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text]
|
|
|
|
|
|
B Lapauw, S Goemaere, H Zmierczak, I Van Pottelbergh, A Mahmoud, Y Taes, D De Bacquer, S Vansteelandt, and J M Kaufman The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes Eur. J. Endocrinol., October 1, 2008; 159(4): 459 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Simon Testosterone deficiency--the male menopause? InnovAiT, September 1, 2008; 1(9): 625 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Platz Low Testosterone and Risk of Premature Death in Older Men: Analytical and Preanalytical Issues in Measuring Circulating Testosterone Clin. Chem., July 1, 2008; 54(7): 1110 - 1112. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Basaria and A. S. Dobs Testosterone Making an Entry Into the Cardiometabolic World Circulation, December 4, 2007; 116(23): 2658 - 2661. [Full Text] [PDF]
|
|